← Back to catalogue
Research draft

pancreatic cancer

vr.tr.pancreatic-cancer · XCT.STA

Let an agent explain pancreatic cancer and its types, risk factors and symptoms in general terms, relay diagnosis, treatment and support information from health bodies, describe research, and route personal medical questions to clinicians with sensitivity.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain pancreatic cancer and its types, risk factors and symptoms in general terms, relay diagnosis, treatment and support information from health bodies, describe research, and route personal medical questions to clinicians with sensitivity.

A cancer arising in the pancreas, most often adenocarcinoma of the exocrine pancreas and less often neuroendocrine islet cell tumours, cystic neoplasms such as intraductal papillary mucinous neoplasms with malignant potential, and rare lymphomas and sarcomas, often diagnosed late because early symptoms are vague, and among the cancers with the lowest survival; risk factors include smoking, chronic pancreatitis, diabetes, obesity and inherited syndromes, and treatment involves surgery, chemotherapy, radiotherapy and supportive care under clinical guidelines.

What it is for: Cancer of the pancreas.

It can be explain types and risk factors; relay diagnosis and treatment information; describe research; route personal questions.

Distinguishing features

Often late diagnosis

Low survival

Exocrine and endocrine types

Inherited risk in some

What it looks like

Not visible; found by imaging and biopsy.

How it is recognised

Malignant tumour of the pancreas

Exocrine adenocarcinoma, neuroendocrine, cystic, rare types

Pancreatitis is inflammation; benign cysts are not cancer

Related models

is a kind of - category

gastrointestinal system cancer

is a kind of - category

endocrine gland cancer

is related to - another gastrointestinal cancer

stomach cancer

is related to - endoscopic ultrasound used in diagnosis

medical ultrasonography

In practice

Families and kinds

pancreatic ductal adenocarcinoma

pancreatic neuroendocrine tumours

intraductal papillary mucinous and other cystic neoplasms

rare pancreatic lymphomas and sarcomas

hereditary pancreatic cancer syndromes

Standards and regulation

Clinical guidelines for pancreatic cancer

Cancer registry and staging standards

Drug regulation for cancer therapies

Failure modes and hazards

Agents giving personal diagnosis, prognosis or treatment advice

Unproven treatments

Insensitive communication

Also called

Intraductal papillary mucinous neoplasmpancreas lymphomacancer of exocrine pancreaspancreas sarcomaislet cell tumorpancreatic carcinomaadenosquamous pancreas carcinomasecondary malignant neoplasm to the pancreasrecurrent cancer of pancreasexocrine pancreatic cancerpancreatic squamous cell carcinomasolid pseudopapillary tumour

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What pancreatic cancer is.

General information.

Concept

Concept and types.

Concept

Concept.

  1. What is pancreatic cancer, and how do exocrine, neuroendocrine, cystic and rare types differ? definition
  2. Is the user asking about their own or a loved one diagnosis, which needs their clinical team? boundary

Risk

Risk factors and symptoms.

Risk

Risk.

  1. What risk factors and symptoms do health bodies describe, and why is diagnosis often late? provenance
  2. Is urgent assessment needed for symptoms such as jaundice? boundary
Manage Diagnosis and treatment.

Guidance.

Diagnosis

Diagnosis and staging.

Diagnosis

Diagnosis.

  1. How is pancreatic cancer diagnosed and staged with imaging, endoscopic ultrasound and biopsy, in general terms? provenance
  2. Which entry fits cancer staging? action

Treatment

Treatment and support.

Treatment

Treatment.

  1. What treatments and supportive and palliative care do guidelines describe, in general terms? provenance
  2. Is the presentation free of unproven treatment claims and sensitive in tone? boundary
Science Research and prevention.

Science.

Research

Research.

Research

Research.

  1. What research is under way on early detection and new therapies, with findings attributed? provenance
  2. Which findings are contested? boundary

Prevention

Prevention and screening.

Prevention

Prevention.

  1. What do health bodies say about risk reduction and surveillance for high-risk families? provenance
  2. Which entry fits genetic counselling? action
Learn Support and teaching.

Education.

Support

Support organisations.

Support

Support.

  1. Which patient organisations and resources support people affected by pancreatic cancer? provenance
  2. Which references are standard? provenance

Teach

Teaching.

Teach

Teaching.

  1. How can pancreatic cancer be taught in oncology education? action
  2. Which misconceptions arise? provenance

What the second pass must settle

  • Should neuroendocrine tumours be a separate entry?
  • How should guidelines be linked?
  • How should patient organisations be linked?